

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.49354222 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.36747336 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.36747336 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.13348136 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.13348136 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.96739132 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.90194831 |
| 8 | lysine metabolic process (GO:0006553) | 6.83977916 |
| 9 | lysine catabolic process (GO:0006554) | 6.83977916 |
| 10 | omega-hydroxylase P450 pathway (GO:0097267) | 6.69906464 |
| 11 | cysteine metabolic process (GO:0006534) | 6.67158318 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.49267371 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.49267371 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.49267371 |
| 15 | * urate metabolic process (GO:0046415) | 6.34990072 |
| 16 | * drug transmembrane transport (GO:0006855) | 6.25173309 |
| 17 | tryptophan metabolic process (GO:0006568) | 6.11229631 |
| 18 | kynurenine metabolic process (GO:0070189) | 5.87042764 |
| 19 | fibrinolysis (GO:0042730) | 5.69544490 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.64598627 |
| 21 | drug catabolic process (GO:0042737) | 5.61153346 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.53380904 |
| 23 | blood coagulation, intrinsic pathway (GO:0007597) | 5.50079222 |
| 24 | homocysteine metabolic process (GO:0050667) | 5.45042460 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.35966448 |
| 26 | exogenous drug catabolic process (GO:0042738) | 5.28936258 |
| 27 | * drug transport (GO:0015893) | 5.26887112 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.14826493 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 5.09644060 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 5.03391479 |
| 31 | serine family amino acid metabolic process (GO:0009069) | 4.93041897 |
| 32 | phenylpropanoid metabolic process (GO:0009698) | 4.89928263 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 4.87160969 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 4.86992973 |
| 35 | cellular modified amino acid catabolic process (GO:0042219) | 4.81620976 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 4.79994927 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.79698519 |
| 38 | oxidative demethylation (GO:0070989) | 4.78714076 |
| 39 | regulation of plasminogen activation (GO:0010755) | 4.69253544 |
| 40 | organic cation transport (GO:0015695) | 4.68804838 |
| 41 | glutamate metabolic process (GO:0006536) | 4.62914641 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 4.60121857 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 4.59072213 |
| 44 | cellular amino acid catabolic process (GO:0009063) | 4.58462994 |
| 45 | * phosphate ion transmembrane transport (GO:0035435) | 4.56524610 |
| 46 | urea metabolic process (GO:0019627) | 4.56300803 |
| 47 | urea cycle (GO:0000050) | 4.56300803 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.51975930 |
| 49 | negative regulation of hemostasis (GO:1900047) | 4.51975930 |
| 50 | serine family amino acid biosynthetic process (GO:0009070) | 4.47201518 |
| 51 | response to mercury ion (GO:0046689) | 4.43477876 |
| 52 | bile acid metabolic process (GO:0008206) | 4.41106871 |
| 53 | amine catabolic process (GO:0009310) | 4.39336574 |
| 54 | cellular biogenic amine catabolic process (GO:0042402) | 4.39336574 |
| 55 | acetyl-CoA metabolic process (GO:0006084) | 4.37498617 |
| 56 | benzene-containing compound metabolic process (GO:0042537) | 4.33774803 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 4.33024710 |
| 58 | ethanol metabolic process (GO:0006067) | 4.31589946 |
| 59 | tyrosine metabolic process (GO:0006570) | 4.29654238 |
| 60 | negative regulation of coagulation (GO:0050819) | 4.27454424 |
| 61 | protein activation cascade (GO:0072376) | 4.26746384 |
| 62 | nitrogen cycle metabolic process (GO:0071941) | 4.26547757 |
| 63 | valine metabolic process (GO:0006573) | 4.26228703 |
| 64 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.25526804 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.23971273 |
| 66 | ketone body metabolic process (GO:1902224) | 4.21199977 |
| 67 | S-adenosylmethionine metabolic process (GO:0046500) | 4.16230040 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 4.15656569 |
| 69 | negative regulation of wound healing (GO:0061045) | 4.13321613 |
| 70 | negative regulation of protein activation cascade (GO:2000258) | 4.12245370 |
| 71 | aldehyde catabolic process (GO:0046185) | 4.11173105 |
| 72 | glycine metabolic process (GO:0006544) | 4.10473674 |
| 73 | branched-chain amino acid metabolic process (GO:0009081) | 4.09521299 |
| 74 | quaternary ammonium group transport (GO:0015697) | 4.07230025 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 4.05958340 |
| 76 | organic acid catabolic process (GO:0016054) | 4.05958340 |
| 77 | fatty acid oxidation (GO:0019395) | 4.04975178 |
| 78 | coenzyme catabolic process (GO:0009109) | 4.03110492 |
| 79 | carnitine metabolic process (GO:0009437) | 4.03106098 |
| 80 | protein carboxylation (GO:0018214) | 4.00536924 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.00536924 |
| 82 | regulation of humoral immune response (GO:0002920) | 3.99930212 |
| 83 | cellular glucuronidation (GO:0052695) | 3.99007039 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98167723 |
| 85 | lipid oxidation (GO:0034440) | 3.97240351 |
| 86 | complement activation, alternative pathway (GO:0006957) | 3.96468458 |
| 87 | tricarboxylic acid metabolic process (GO:0072350) | 3.95410033 |
| 88 | negative regulation of fibrinolysis (GO:0051918) | 3.94449060 |
| 89 | ethanol oxidation (GO:0006069) | 3.93254398 |
| 90 | complement activation (GO:0006956) | 3.90715846 |
| 91 | hormone catabolic process (GO:0042447) | 3.89987321 |
| 92 | complement activation, classical pathway (GO:0006958) | 3.89552167 |
| 93 | regulation of protein activation cascade (GO:2000257) | 3.84884663 |
| 94 | artery smooth muscle contraction (GO:0014824) | 3.83394078 |
| 95 | sodium-independent organic anion transport (GO:0043252) | 3.81892704 |
| 96 | monocarboxylic acid catabolic process (GO:0072329) | 3.81724294 |
| 97 | branched-chain amino acid catabolic process (GO:0009083) | 3.80957460 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.80760092 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.80760092 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.78748188 |
| 101 | * phosphate ion transport (GO:0006817) | 3.78539606 |
| 102 | regulation of fibrinolysis (GO:0051917) | 3.74980259 |
| 103 | negative regulation of complement activation (GO:0045916) | 3.73995736 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.73709620 |
| 105 | drug metabolic process (GO:0017144) | 3.71064512 |
| 106 | positive regulation of blood coagulation (GO:0030194) | 3.70380233 |
| 107 | positive regulation of hemostasis (GO:1900048) | 3.70380233 |
| 108 | alkaloid metabolic process (GO:0009820) | 3.69352756 |
| 109 | negative regulation of cholesterol transport (GO:0032375) | 3.68214080 |
| 110 | negative regulation of sterol transport (GO:0032372) | 3.68214080 |
| 111 | high-density lipoprotein particle remodeling (GO:0034375) | 3.67116009 |
| 112 | metanephric tubule development (GO:0072170) | 3.67001976 |
| 113 | metanephric nephron tubule development (GO:0072234) | 3.67001976 |
| 114 | indole-containing compound metabolic process (GO:0042430) | 3.66084207 |
| 115 | tonic smooth muscle contraction (GO:0014820) | 3.64151745 |
| 116 | metanephric nephron epithelium development (GO:0072243) | 3.62617423 |
| 117 | steroid catabolic process (GO:0006706) | 3.62254498 |
| 118 | regulation of complement activation (GO:0030449) | 3.61909262 |
| 119 | phospholipid efflux (GO:0033700) | 3.59278213 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 3.57943575 |
| 121 | macromolecular complex remodeling (GO:0034367) | 3.57943575 |
| 122 | plasma lipoprotein particle remodeling (GO:0034369) | 3.57943575 |
| 123 | fructose metabolic process (GO:0006000) | 3.57638273 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55546658 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55546658 |
| 126 | acylglycerol homeostasis (GO:0055090) | 3.53868946 |
| 127 | triglyceride homeostasis (GO:0070328) | 3.53868946 |
| 128 | acute-phase response (GO:0006953) | 3.51663919 |
| 129 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.51118554 |
| 130 | bile acid and bile salt transport (GO:0015721) | 3.49020706 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 3.47992373 |
| 132 | small molecule catabolic process (GO:0044282) | 3.47308998 |
| 133 | arginine metabolic process (GO:0006525) | 3.46529398 |
| 134 | regulation of cholesterol esterification (GO:0010872) | 3.45904988 |
| 135 | dicarboxylic acid metabolic process (GO:0043648) | 3.45382232 |
| 136 | flavonoid metabolic process (GO:0009812) | 3.45143047 |
| 137 | vitamin D metabolic process (GO:0042359) | 3.44620319 |
| 138 | negative regulation of lipase activity (GO:0060192) | 3.43667478 |
| 139 | regulation of triglyceride catabolic process (GO:0010896) | 3.42465560 |
| 140 | xenobiotic metabolic process (GO:0006805) | 3.41130568 |
| 141 | negative regulation of metanephros development (GO:0072217) | 3.40538116 |
| 142 | imidazole-containing compound metabolic process (GO:0052803) | 3.40422113 |
| 143 | positive regulation of coagulation (GO:0050820) | 3.39783981 |
| 144 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.38564519 |
| 145 | response to phenylpropanoid (GO:0080184) | 3.37103348 |
| 146 | cholesterol efflux (GO:0033344) | 3.36534922 |
| 147 | metanephric epithelium development (GO:0072207) | 3.30450061 |
| 148 | nephron tubule formation (GO:0072079) | 3.17209118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.98352011 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.83615881 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.13339962 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.97151919 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.87945622 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.55243033 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.07566450 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76384103 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.54204446 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.73080975 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44317877 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39128284 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.17403925 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.09637106 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0346787 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89581432 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76647881 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.74512351 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67982363 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.58898707 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53044668 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43110907 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42590533 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38515799 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37171670 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29316840 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27848771 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27624768 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20696546 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19671034 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18248781 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15912739 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09030752 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04721032 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03746346 |
| 36 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00441664 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97569778 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97414681 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92384745 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91852183 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90431165 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90219083 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88840821 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84852456 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84648599 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83940800 |
| 47 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83710087 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83426711 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83208375 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83006466 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82828128 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82468479 |
| 53 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.78707187 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78540771 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.77485938 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75729231 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.75721832 |
| 58 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75381756 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.75023332 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74627098 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.73788114 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73570730 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73063715 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73005136 |
| 65 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72722328 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72116850 |
| 67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71735110 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71577458 |
| 69 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.71163325 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70900498 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70900498 |
| 72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.70800421 |
| 73 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69588138 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69377821 |
| 75 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.68946129 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68272597 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67836855 |
| 78 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.67284718 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67192791 |
| 80 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.66447654 |
| 81 | NFYA_21822215_ChIP-Seq_K562_Human | 0.66314151 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.65329421 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64057819 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63545585 |
| 85 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63161136 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.62618525 |
| 87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.62498538 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.62464743 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.62389178 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60894891 |
| 91 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60582724 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.59427509 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58390081 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.58288488 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57867052 |
| 96 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.57728987 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.57624556 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.57217477 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.57162378 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.56972046 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.56842861 |
| 102 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56825189 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.56753288 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.55870349 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.55591832 |
| 106 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55432554 |
| 107 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55206398 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.54814897 |
| 109 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.54782406 |
| 110 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54626435 |
| 111 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54614843 |
| 112 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.54417434 |
| 113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.54212131 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.54032967 |
| 115 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.53676771 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53443091 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52018276 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.51329421 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.51329421 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50646409 |
| 121 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.50637146 |
| 122 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50619798 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50351887 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.50244722 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49947454 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49392879 |
| 127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49023779 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48937799 |
| 129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.48913919 |
| 130 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.48891137 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48463505 |
| 132 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47281543 |
| 133 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46728347 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.46348119 |
| 135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46150295 |
| 136 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45363426 |
| 137 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.45113116 |
| 138 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.44093420 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.43909427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.46847617 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.67841355 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.34299864 |
| 4 | MP0005365_abnormal_bile_salt | 5.16739536 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.70409442 |
| 6 | MP0005332_abnormal_amino_acid | 4.00515815 |
| 7 | MP0003252_abnormal_bile_duct | 3.76678574 |
| 8 | MP0003195_calcinosis | 3.70464962 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.59816770 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.52405684 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.06593433 |
| 12 | MP0004043_abnormal_pH_regulation | 2.83727401 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.69047246 |
| 14 | MP0009643_abnormal_urine_homeostasis | 2.52188138 |
| 15 | MP0005083_abnormal_biliary_tract | 2.18751589 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.18718352 |
| 17 | MP0009840_abnormal_foam_cell | 2.01707478 |
| 18 | MP0005636_abnormal_mineral_homeostasis | 1.97586111 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.91604694 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82992048 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.79476702 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.75202955 |
| 23 | MP0000609_abnormal_liver_physiology | 1.73301091 |
| 24 | MP0001765_abnormal_ion_homeostasis | 1.72599427 |
| 25 | MP0001756_abnormal_urination | 1.69606502 |
| 26 | MP0003186_abnormal_redox_activity | 1.60864188 |
| 27 | MP0001764_abnormal_homeostasis | 1.58556006 |
| 28 | MP0002136_abnormal_kidney_physiology | 1.55761865 |
| 29 | MP0005451_abnormal_body_composition | 1.45058523 |
| 30 | MP0003868_abnormal_feces_composition | 1.23213459 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.20253089 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.13001153 |
| 33 | MP0004272_abnormal_basement_membrane | 1.10232093 |
| 34 | MP0010386_abnormal_urinary_bladder | 1.09436907 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.09190767 |
| 36 | MP0003879_abnormal_hair_cell | 1.08241671 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.03201551 |
| 38 | MP0000598_abnormal_liver_morphology | 1.01569970 |
| 39 | MP0009764_decreased_sensitivity_to | 0.98286006 |
| 40 | MP0005670_abnormal_white_adipose | 0.95520458 |
| 41 | MP0002928_abnormal_bile_duct | 0.93787656 |
| 42 | MP0005535_abnormal_body_temperature | 0.92902230 |
| 43 | MP0009642_abnormal_blood_homeostasis | 0.90715857 |
| 44 | MP0001661_extended_life_span | 0.83745542 |
| 45 | MP0008469_abnormal_protein_level | 0.83632400 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 0.82077299 |
| 47 | MP0005647_abnormal_sex_gland | 0.80527897 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 0.80405967 |
| 49 | MP0005377_hearing/vestibular/ear_phenot | 0.79973105 |
| 50 | MP0003878_abnormal_ear_physiology | 0.79973105 |
| 51 | MP0000538_abnormal_urinary_bladder | 0.79111082 |
| 52 | MP0005408_hypopigmentation | 0.77178068 |
| 53 | MP0003011_delayed_dark_adaptation | 0.77086100 |
| 54 | MP0000604_amyloidosis | 0.76967586 |
| 55 | MP0001958_emphysema | 0.75779915 |
| 56 | MP0008961_abnormal_basal_metabolism | 0.75386603 |
| 57 | MP0002132_abnormal_respiratory_system | 0.74749969 |
| 58 | MP0001915_intracranial_hemorrhage | 0.74734094 |
| 59 | MP0002168_other_aberrant_phenotype | 0.72551348 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 0.71906987 |
| 61 | MP0000230_abnormal_systemic_arterial | 0.70450454 |
| 62 | MP0009763_increased_sensitivity_to | 0.70304795 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 0.69771671 |
| 64 | MP0003638_abnormal_response/metabolism_ | 0.66371176 |
| 65 | MP0005376_homeostasis/metabolism_phenot | 0.63441811 |
| 66 | MP0003183_abnormal_peptide_metabolism | 0.63291013 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.62880831 |
| 68 | MP0003300_gastrointestinal_ulcer | 0.61904688 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.61772780 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.61207938 |
| 71 | MP0003329_amyloid_beta_deposits | 0.61120184 |
| 72 | MP0002135_abnormal_kidney_morphology | 0.61060996 |
| 73 | MP0009697_abnormal_copulation | 0.60168248 |
| 74 | MP0005395_other_phenotype | 0.59799712 |
| 75 | MP0000534_abnormal_ureter_morphology | 0.59398617 |
| 76 | MP0002971_abnormal_brown_adipose | 0.58601127 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.57962329 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 0.53640174 |
| 79 | MP0004885_abnormal_endolymph | 0.52989358 |
| 80 | MP0004147_increased_porphyrin_level | 0.50800345 |
| 81 | MP0005187_abnormal_penis_morphology | 0.50450347 |
| 82 | MP0000249_abnormal_blood_vessel | 0.50119075 |
| 83 | MP0002796_impaired_skin_barrier | 0.49974892 |
| 84 | MP0005334_abnormal_fat_pad | 0.49336210 |
| 85 | MP0005266_abnormal_metabolism | 0.48458035 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.46795401 |
| 87 | MP0003690_abnormal_glial_cell | 0.46414897 |
| 88 | MP0003953_abnormal_hormone_level | 0.46122114 |
| 89 | MP0002254_reproductive_system_inflammat | 0.45352710 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 0.44338295 |
| 91 | MP0003724_increased_susceptibility_to | 0.43265083 |
| 92 | MP0004130_abnormal_muscle_cell | 0.42463575 |
| 93 | MP0005197_abnormal_uvea_morphology | 0.41888641 |
| 94 | MP0005023_abnormal_wound_healing | 0.41055770 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.40703453 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.40562851 |
| 97 | MP0009785_altered_susceptibility_to | 0.39877612 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.39835301 |
| 99 | MP0003959_abnormal_lean_body | 0.39609214 |
| 100 | MP0000467_abnormal_esophagus_morphology | 0.39225888 |
| 101 | MP0008775_abnormal_heart_ventricle | 0.39067152 |
| 102 | MP0009672_abnormal_birth_weight | 0.38431316 |
| 103 | MP0009053_abnormal_anal_canal | 0.37558865 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.36598626 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.36397375 |
| 106 | MP0003283_abnormal_digestive_organ | 0.36343876 |
| 107 | MP0005166_decreased_susceptibility_to | 0.36092712 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.36003689 |
| 109 | MP0008874_decreased_physiological_sensi | 0.35258845 |
| 110 | MP0001944_abnormal_pancreas_morphology | 0.34098832 |
| 111 | MP0003075_altered_response_to | 0.33328346 |
| 112 | MP0003045_fibrosis | 0.32882083 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.31273419 |
| 114 | MP0000920_abnormal_myelination | 0.31065948 |
| 115 | MP0004510_myositis | 0.30383676 |
| 116 | MP0008872_abnormal_physiological_respon | 0.30239689 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.30193386 |
| 118 | MP0002090_abnormal_vision | 0.29481349 |
| 119 | MP0008873_increased_physiological_sensi | 0.29339196 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.29141754 |
| 121 | MP0002269_muscular_atrophy | 0.28392650 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.28094182 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.27878959 |
| 124 | MP0005164_abnormal_response_to | 0.27075859 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.26991671 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.26849197 |
| 127 | MP0000371_diluted_coat_color | 0.25356363 |
| 128 | MP0005448_abnormal_energy_balance | 0.24919572 |
| 129 | MP0002069_abnormal_eating/drinking_beha | 0.24722455 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.24171133 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.23972922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.76606653 |
| 2 | Gout (HP:0001997) | 5.65174711 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.29651259 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.24627217 |
| 5 | Hyperglycinuria (HP:0003108) | 5.18085368 |
| 6 | Glomerulonephritis (HP:0000099) | 4.80032516 |
| 7 | Abnormality of glycine metabolism (HP:0010895) | 4.72492969 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.72492969 |
| 9 | Xanthomatosis (HP:0000991) | 4.64738789 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.64027451 |
| 11 | Potter facies (HP:0002009) | 4.61463063 |
| 12 | Facial shape deformation (HP:0011334) | 4.61463063 |
| 13 | Ketosis (HP:0001946) | 4.57160695 |
| 14 | Deep venous thrombosis (HP:0002625) | 4.53880810 |
| 15 | Hyperglycinemia (HP:0002154) | 4.40885316 |
| 16 | Increased circulating renin level (HP:0000848) | 4.34951085 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 4.32318948 |
| 18 | Hypokalemic alkalosis (HP:0001949) | 4.27498310 |
| 19 | Proximal tubulopathy (HP:0000114) | 4.24481164 |
| 20 | Hyperammonemia (HP:0001987) | 4.20496012 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.16784835 |
| 22 | Ketoacidosis (HP:0001993) | 4.14297411 |
| 23 | Increased purine levels (HP:0004368) | 4.02731786 |
| 24 | Hyperuricemia (HP:0002149) | 4.02731786 |
| 25 | Metabolic alkalosis (HP:0200114) | 4.01625613 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.97517498 |
| 27 | Alkalosis (HP:0001948) | 3.85710597 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84619465 |
| 29 | Abnormality of nucleobase metabolism (HP:0010932) | 3.83105412 |
| 30 | Hypomagnesemia (HP:0002917) | 3.80459355 |
| 31 | Nephritis (HP:0000123) | 3.75737939 |
| 32 | Prolonged partial thromboplastin time (HP:0003645) | 3.73725776 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.71213734 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 3.68617399 |
| 35 | Polyuria (HP:0000103) | 3.63211475 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.62918516 |
| 37 | Abnormal urine output (HP:0012590) | 3.60978654 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.57471884 |
| 39 | Abnormality of chloride homeostasis (HP:0011422) | 3.52600764 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43864390 |
| 41 | Abnormality of renal excretion (HP:0011036) | 3.39028394 |
| 42 | Complement deficiency (HP:0004431) | 3.33024092 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 3.32424736 |
| 44 | Vascular calcification (HP:0004934) | 3.19688921 |
| 45 | Joint hemorrhage (HP:0005261) | 3.18843108 |
| 46 | Abnormality of magnesium homeostasis (HP:0004921) | 3.16231771 |
| 47 | Hypoglycemic coma (HP:0001325) | 3.15598873 |
| 48 | Abnormality of urine glucose concentration (HP:0011016) | 3.12371365 |
| 49 | Glycosuria (HP:0003076) | 3.12371365 |
| 50 | Focal segmental glomerulosclerosis (HP:0000097) | 3.11336762 |
| 51 | Metabolic acidosis (HP:0001942) | 3.05364266 |
| 52 | Fat malabsorption (HP:0002630) | 3.02804370 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97035572 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.97035572 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.91284721 |
| 56 | Spontaneous abortion (HP:0005268) | 2.89110483 |
| 57 | Epidermoid cyst (HP:0200040) | 2.88074734 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.84678341 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.83936336 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.81652956 |
| 61 | Polydipsia (HP:0001959) | 2.80720403 |
| 62 | Abnormal drinking behavior (HP:0030082) | 2.80720403 |
| 63 | Osteomalacia (HP:0002749) | 2.80215997 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.79675171 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.79675171 |
| 66 | Lethargy (HP:0001254) | 2.78481064 |
| 67 | Hypolipoproteinemia (HP:0010981) | 2.74820119 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.74549445 |
| 69 | Hemorrhage of the eye (HP:0011885) | 2.68836586 |
| 70 | Rickets (HP:0002748) | 2.68531189 |
| 71 | Mitral stenosis (HP:0001718) | 2.65752393 |
| 72 | Malnutrition (HP:0004395) | 2.65518332 |
| 73 | Menorrhagia (HP:0000132) | 2.64574932 |
| 74 | Enlarged kidneys (HP:0000105) | 2.63870884 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.63810901 |
| 76 | Tetany (HP:0001281) | 2.63790508 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.60456814 |
| 78 | Renal salt wasting (HP:0000127) | 2.60443551 |
| 79 | Vomiting (HP:0002013) | 2.59810068 |
| 80 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59247006 |
| 81 | Purpura (HP:0000979) | 2.58894594 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 2.58805363 |
| 83 | Glomerulosclerosis (HP:0000096) | 2.58219423 |
| 84 | Abnormality of renin-angiotensin system (HP:0000847) | 2.58183564 |
| 85 | Renal tubular acidosis (HP:0001947) | 2.55838965 |
| 86 | Nephrolithiasis (HP:0000787) | 2.55588543 |
| 87 | Hyperaldosteronism (HP:0000859) | 2.53340620 |
| 88 | Hyperphosphaturia (HP:0003109) | 2.53126105 |
| 89 | Hyperbilirubinemia (HP:0002904) | 2.52944448 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.49721656 |
| 91 | Gingival bleeding (HP:0000225) | 2.48644374 |
| 92 | Irritability (HP:0000737) | 2.42926860 |
| 93 | Hypoalphalipoproteinemia (HP:0003233) | 2.41246466 |
| 94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.41194825 |
| 95 | Neonatal onset (HP:0003623) | 2.40683231 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 2.37138655 |
| 97 | Spastic diplegia (HP:0001264) | 2.34651781 |
| 98 | Abnormality of complement system (HP:0005339) | 2.31471105 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 2.27482450 |
| 100 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25255711 |
| 101 | Hypophosphatemia (HP:0002148) | 2.24165254 |
| 102 | Steatorrhea (HP:0002570) | 2.22763045 |
| 103 | Late onset (HP:0003584) | 2.22556293 |
| 104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.22175392 |
| 105 | Cerebral edema (HP:0002181) | 2.22150983 |
| 106 | Confusion (HP:0001289) | 2.21859537 |
| 107 | Chorioretinal atrophy (HP:0000533) | 2.16436681 |
| 108 | Pulmonary embolism (HP:0002204) | 2.13998490 |
| 109 | Hypercalciuria (HP:0002150) | 2.11182743 |
| 110 | Arthropathy (HP:0003040) | 2.09607723 |
| 111 | Hypercholesterolemia (HP:0003124) | 2.08207087 |
| 112 | Abnormal platelet function (HP:0011869) | 2.06131794 |
| 113 | Impaired platelet aggregation (HP:0003540) | 2.06131794 |
| 114 | Hypophosphatemic rickets (HP:0004912) | 2.06092741 |
| 115 | Abnormal gallbladder physiology (HP:0012438) | 2.04027953 |
| 116 | Cholecystitis (HP:0001082) | 2.04027953 |
| 117 | Thrombophlebitis (HP:0004418) | 2.01483041 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 2.01352466 |
| 119 | Pancreatitis (HP:0001733) | 1.99865169 |
| 120 | Increased mean platelet volume (HP:0011877) | 1.99133154 |
| 121 | Systemic lupus erythematosus (HP:0002725) | 1.98125230 |
| 122 | Nephrocalcinosis (HP:0000121) | 1.96138605 |
| 123 | Nausea (HP:0002018) | 1.95940519 |
| 124 | Abnormality of macular pigmentation (HP:0008002) | 1.93700265 |
| 125 | Methylmalonic aciduria (HP:0012120) | 1.92239204 |
| 126 | Hypokalemia (HP:0002900) | 1.92045677 |
| 127 | Fair hair (HP:0002286) | 1.90040438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 6.58148447 |
| 2 | WNK3 | 6.19196287 |
| 3 | BCKDK | 5.83216615 |
| 4 | OXSR1 | 5.46857673 |
| 5 | FGFR4 | 3.12727060 |
| 6 | STK39 | 2.91741983 |
| 7 | ERN1 | 2.64206991 |
| 8 | STK38L | 2.40381473 |
| 9 | SIK1 | 2.31774991 |
| 10 | PIK3CA | 2.26612079 |
| 11 | MST1R | 2.01152148 |
| 12 | INSRR | 1.79333165 |
| 13 | ERBB4 | 1.76695453 |
| 14 | PDK3 | 1.64583796 |
| 15 | PDK4 | 1.64583796 |
| 16 | NTRK1 | 1.58351984 |
| 17 | SGK223 | 1.54754884 |
| 18 | SGK494 | 1.54754884 |
| 19 | EPHA2 | 1.51515604 |
| 20 | BLK | 1.45808825 |
| 21 | NEK1 | 1.44947206 |
| 22 | MAPK11 | 1.36390189 |
| 23 | TAOK3 | 1.32343862 |
| 24 | PINK1 | 1.24741279 |
| 25 | MAP2K4 | 1.23612246 |
| 26 | PDGFRA | 1.15732856 |
| 27 | MAP3K7 | 1.12951178 |
| 28 | GRK6 | 1.12521875 |
| 29 | SGK3 | 1.11051752 |
| 30 | ABL2 | 1.10031682 |
| 31 | TRIB3 | 1.06551150 |
| 32 | WNK1 | 1.05672507 |
| 33 | PDK2 | 1.05233102 |
| 34 | SGK2 | 1.04680207 |
| 35 | STK38 | 1.03737768 |
| 36 | PTK6 | 1.03651378 |
| 37 | LATS1 | 1.01436692 |
| 38 | TTN | 1.00215745 |
| 39 | EPHB1 | 0.95306920 |
| 40 | PIK3CG | 0.92444218 |
| 41 | FRK | 0.87861764 |
| 42 | GSK3A | 0.87674128 |
| 43 | PRKAA2 | 0.85662567 |
| 44 | PKN2 | 0.85077668 |
| 45 | KIT | 0.84857983 |
| 46 | MAP3K3 | 0.80585289 |
| 47 | TIE1 | 0.80548630 |
| 48 | FGFR3 | 0.80201310 |
| 49 | TYK2 | 0.80022601 |
| 50 | DYRK1B | 0.78736081 |
| 51 | MOS | 0.76680951 |
| 52 | TRPM7 | 0.75540840 |
| 53 | DAPK2 | 0.75469481 |
| 54 | NEK9 | 0.74586789 |
| 55 | JAK2 | 0.74504964 |
| 56 | PRKAA1 | 0.73842085 |
| 57 | MAP3K14 | 0.71552523 |
| 58 | PRKCZ | 0.70705528 |
| 59 | CAMKK2 | 0.69554026 |
| 60 | MET | 0.68399552 |
| 61 | PTK2 | 0.68209989 |
| 62 | PRPF4B | 0.66026218 |
| 63 | MAPK15 | 0.64501410 |
| 64 | PAK2 | 0.63465214 |
| 65 | TGFBR2 | 0.62960293 |
| 66 | EPHB2 | 0.62433923 |
| 67 | MAP2K3 | 0.61889925 |
| 68 | ZAP70 | 0.61687378 |
| 69 | PRKD2 | 0.61016047 |
| 70 | LRRK2 | 0.59996438 |
| 71 | SRC | 0.59849449 |
| 72 | FLT3 | 0.59820252 |
| 73 | KDR | 0.59817112 |
| 74 | EPHA3 | 0.58451083 |
| 75 | PDPK1 | 0.57114022 |
| 76 | CSF1R | 0.55414104 |
| 77 | FGFR2 | 0.55192065 |
| 78 | PRKCE | 0.53390417 |
| 79 | PRKACG | 0.51432503 |
| 80 | ERBB2 | 0.51220832 |
| 81 | IRAK3 | 0.48414562 |
| 82 | NTRK3 | 0.47253304 |
| 83 | MAPK4 | 0.46985560 |
| 84 | CDK9 | 0.46256654 |
| 85 | INSR | 0.46230322 |
| 86 | RIPK1 | 0.46064624 |
| 87 | JAK3 | 0.45050315 |
| 88 | MAPK12 | 0.44260753 |
| 89 | MAP3K9 | 0.43763210 |
| 90 | ICK | 0.42954619 |
| 91 | JAK1 | 0.40180435 |
| 92 | PRKG1 | 0.39159128 |
| 93 | TBK1 | 0.38555503 |
| 94 | MAP3K11 | 0.38220272 |
| 95 | SGK1 | 0.37199994 |
| 96 | PAK3 | 0.36130261 |
| 97 | PDK1 | 0.35552733 |
| 98 | MAP3K13 | 0.35523295 |
| 99 | RPS6KA3 | 0.35344037 |
| 100 | CDC42BPA | 0.34573846 |
| 101 | CSK | 0.34207993 |
| 102 | PRKCB | 0.33205803 |
| 103 | MAP3K10 | 0.32778307 |
| 104 | IRAK2 | 0.32084386 |
| 105 | MAPKAPK3 | 0.31002170 |
| 106 | EPHA4 | 0.30777801 |
| 107 | DDR2 | 0.30501549 |
| 108 | MAP2K6 | 0.30186056 |
| 109 | CAMK2G | 0.29855710 |
| 110 | RPS6KA2 | 0.28244494 |
| 111 | PRKCQ | 0.27226060 |
| 112 | PRKACB | 0.25916677 |
| 113 | CDK6 | 0.23453582 |
| 114 | PRKCG | 0.23363712 |
| 115 | IGF1R | 0.22644627 |
| 116 | PRKCA | 0.22282642 |
| 117 | CSNK1G1 | 0.21474999 |
| 118 | IRAK1 | 0.21376510 |
| 119 | FER | 0.21302497 |
| 120 | PRKCD | 0.20473751 |
| 121 | MTOR | 0.20396374 |
| 122 | BMX | 0.19085417 |
| 123 | GRK1 | 0.18597293 |
| 124 | MAP3K2 | 0.16851251 |
| 125 | MYLK | 0.15793266 |
| 126 | PRKCH | 0.15020242 |
| 127 | PRKACA | 0.14808686 |
| 128 | CAMK4 | 0.14760969 |
| 129 | EGFR | 0.13563383 |
| 130 | CAMK1G | 0.13221375 |
| 131 | MAPK7 | 0.13055899 |
| 132 | AKT2 | 0.12602622 |
| 133 | MAP3K6 | 0.12401703 |
| 134 | CAMK1D | 0.12358967 |
| 135 | STK11 | 0.12309617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.62812312 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49297484 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.06042348 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03113105 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.01167771 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.88075012 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.81092132 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73428907 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.61827848 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59480710 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.53769189 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53183198 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52964310 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.51638775 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.42778735 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41161898 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.17240253 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09661009 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.91571180 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89860153 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.86891723 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85391144 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.84034049 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78173574 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73526182 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70932808 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.65656944 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59363713 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57778172 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56625650 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55057296 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54369737 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52550611 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52377923 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47881625 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42199886 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41812914 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39925519 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36740461 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31592525 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29114871 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27003766 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20005665 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18850879 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18532746 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16018574 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14096111 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11549907 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.07915464 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06138017 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05105993 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03283012 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94224237 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92501414 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92152898 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.91027971 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89666060 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80831189 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75340296 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71505108 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70328485 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66704924 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60014098 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56640178 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52661868 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51648178 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47323315 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36244976 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35166496 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26995441 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26991190 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24785648 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.23784506 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.23664429 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19776696 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.18315329 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16855809 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16121934 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14228744 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13816902 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.13652319 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12440673 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12017452 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11222400 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.10497535 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08467326 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.05806469 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05438042 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04377484 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.03984790 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.03779049 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03478589 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.02868996 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01184846 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00810513 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.00388715 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00334675 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1836474 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | -0.1808761 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1712102 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1609975 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | -0.1513884 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1407292 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1333515 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1308181 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1243222 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.1162548 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0756145 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0599729 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0481031 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0456224 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0049885 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0025667 |

